Clinical Trial Update: Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating XS411 for early-onset Parkinson disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• XS411

Snippet

Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | Conditions: Parkinson Disease (PD) | Phase 1, Phase 2 | Status: RECRUITING